Phosphoserine Antikörper (phosphorylated) (Biotin)

Produktnummer ABIN2178435

Dieser Anti-Phosphoserine Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von Phosphoserine in WB, ELISA, IHC (p) und IHC (fro). Geeignet für Maus.

Kurzübersicht für Phosphoserine Antikörper (phosphorylated) (Biotin) (ABIN2178435)

Target: Phosphoserine

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Phosphoserine Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-Phosphoserine Antikörper (Biotin)

Bindungsspezifität: phosphorylated

Kreuzreaktivität: Maus

Homologie: Human,Rat,Dog,Cow,Chicken,Monkey,Goose

Aufreinigung: Purified by Protein A.

Immunogen: Phosphoserine-KLH

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu Phosphoserine

Target: Phosphoserine

Substanzklasse: Amino Acid

Hintergrund:

Synonyms: Ser, pS, p-S, pSER, p-SER.

Background: Changes in the serine/threonine phosphorylation state of a protein in response to various external stimuli can have profound effects on cellular signal transduction, apoptosis and carcinogenesis. The reagents, including phosphorylated protein/peptides, antibodies against the phosphospecific amino acid, are important tools to explore the activation of serine, threonine or tyrosine containing proteins. An aberrant protein phosphorylation is a hallmark of human disease, and the enzymes, particularly protein kinases, which control protein phosphorylation are recognized as a major new drug target family.